Virginia Tech Scientists Lead Study on Tobacco Tax Impact

Nov.22.2022
Virginia Tech Scientists Lead Study on Tobacco Tax Impact
A $3.5 million, five-year study at Virginia Tech predicts tobacco tax effects on public health through a complex experimental market.

Scientists at the Fralin Biomedical Research Institute at Virginia Tech are leading a five-year, $3.5 million research project to predict the impact of tobacco taxes on health.


Taxation is one of the most effective ways to change behavior - it makes people think about their choices, including their choice to use tobacco," said Warren Bickel, professor at the Fralin Biomedical Research Institute and director of the Addictions Recovery Center at the institute.


Bickel's research project, funded by the National Cancer Institute of the National Institutes of Health in the United States, aims to predict the impact of tobacco tax proposals in a complex experimental market. This market is constantly evolving with the introduction of new products, such as low-nicotine cigarettes or electronic cigarettes.


According to Virginia Tech, this project could potentially provide research-based health policy guidance for new tobacco regulations and assess the impact of people's economic choices on health.


Taxation is one of the most effective ways to change behavior - it makes people consider their choices, including their choice to use tobacco.


Warren Bickel, Director of the Addictions Recovery Research Center at the Fralin Biomedical Research Institute.


Taxes can help people achieve better health by discouraging them from smoking. If you make the product more expensive, people will be less likely to use it. They can also encourage people to switch from the most harmful tobacco products to the least harmful ones," said Bickel, who is also the director of the research institute's Health Behavior Research Center.


He will consider health disparities related to tobacco by investigating socio-economic factors.


Smoking rates are higher among low-income populations, and disproportionate tax policies may have far-reaching direct and unforeseen effects," said Professor Becker of the Virginia Tech College of Science.


To gain definitive answers, Bickel's approach involves conducting experiments in the tobacco market, which is an invention of the Center for Addictions Recovery Research. Participants have an account and purchase tobacco products to reflect their typical buying behavior. Joint researchers involved in the project include Jeff Stein and Allison Tegge from the Fralin Biomedical Research Institute and Bickel.


The market places a combination of products, prices, and specific regulations under experimental control to enable researchers to estimate the impact of policies in a realistic environment.


In this context, researchers can predict the impact and health equity of proposed tax policies, including a proposal for equal taxation of all tobacco products, as well as other proposals based on the product's nicotine content, potential harm, or whether the tobacco product is already taxed. The FDA's revised risk designation.


We can implement policies in the experimental tobacco market and provide information on the effects of tobacco purchases on people," said Bickel. "For example, if legislators or regulators restrict access to one product over another, will it lead smokers to make less healthy or healthier choices? It is an ideal resource for studying the harm reduction potential of low-nicotine cigarettes and alternative nicotine products.


Statement:


This article has been compiled from third-party information and is intended for industry professionals for discussion and educational purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article. The compilation of this article is only intended for industry communication and research purposes.


As the translation is limited by the compiler's ability, the translated article may not fully convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
KT&G Q4 and Full-Year 2025 Results: Global CC Strongest, NGP Penetration Expands
KT&G Q4 and Full-Year 2025 Results: Global CC Strongest, NGP Penetration Expands
According to KT&G’s official website (Feb 5, 2026), KT&G released its 2025 fourth-quarter and full-year results. Driven by strong growth in its overseas cigarette business and a rebound in its real estate business, the company posted double-digit increases in both revenue and operating profit, reaching record-high performance.
Feb.05 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Special Report | New Patents Show China Tobacco Hubei Industrial Testing Gas-Releasing Nicotine Pouches
Newly published patent filings indicate that China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), is exploring nicotine pouch technologies capable of releasing gas during oral use. The designs include carbon-dioxide microcapsules that burst in the mouth and effervescent systems that generate gas through chemical reactions with saliva, suggesting efforts to introduce new sensory dynamics into modern oral nicotine products.
News
Mar.04
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia will introduce an extrajudicial (non-court) blocking mechanism starting March 1, 2026, allowing authorities to block websites selling tobacco and nicotine-containing products online without a court order. State Duma member Anton Nemkin said the change will place offending sites directly onto the prohibited information registry, speeding up enforcement, reducing the court burden, and increasing platform obligations to proactively monitor content.
Jan.29 by 2FIRSTS.ai
BAT rolls out VELO nicotine pouches in Argentina as social media buzzes about ZYN distribution
BAT rolls out VELO nicotine pouches in Argentina as social media buzzes about ZYN distribution
BAT Argentina says it has launched VELO nicotine pouches in Argentina, positioning the product as an adult alternative that contains no tobacco and involves no combustion. At the same time, social media discussion and media reporting indicate that Philip Morris International’s ZYN nicotine pouches are also being distributed through Argentine channels.
Jan.12 by 2FIRSTS.ai